ATE233244T1 - Carboxylsäure substituierte heterocyclische verbindungen als metalloproteinase inhibitoren - Google Patents
Carboxylsäure substituierte heterocyclische verbindungen als metalloproteinase inhibitorenInfo
- Publication number
- ATE233244T1 ATE233244T1 AT98964135T AT98964135T ATE233244T1 AT E233244 T1 ATE233244 T1 AT E233244T1 AT 98964135 T AT98964135 T AT 98964135T AT 98964135 T AT98964135 T AT 98964135T AT E233244 T1 ATE233244 T1 AT E233244T1
- Authority
- AT
- Austria
- Prior art keywords
- carboxylic acid
- acid substituted
- substituted heterocyclic
- heterocyclic compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6820097P | 1997-12-19 | 1997-12-19 | |
US09/213,031 US6335329B1 (en) | 1997-12-19 | 1998-12-16 | Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
PCT/US1998/027082 WO1999032452A1 (en) | 1997-12-19 | 1998-12-18 | Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE233244T1 true ATE233244T1 (de) | 2003-03-15 |
Family
ID=26748692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98964135T ATE233244T1 (de) | 1997-12-19 | 1998-12-18 | Carboxylsäure substituierte heterocyclische verbindungen als metalloproteinase inhibitoren |
Country Status (15)
Country | Link |
---|---|
US (5) | US6335329B1 (de) |
EP (1) | EP1042297B1 (de) |
JP (1) | JP2001526267A (de) |
KR (1) | KR100446706B1 (de) |
CN (1) | CN1110482C (de) |
AT (1) | ATE233244T1 (de) |
AU (1) | AU746957B2 (de) |
CA (1) | CA2315826C (de) |
DE (1) | DE69811734T2 (de) |
DK (1) | DK1042297T3 (de) |
ES (1) | ES2191986T3 (de) |
HK (1) | HK1034964A1 (de) |
HU (1) | HUP0100056A3 (de) |
IL (2) | IL136717A0 (de) |
WO (1) | WO1999032452A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7037767B2 (en) * | 2003-03-24 | 2006-05-02 | Konica Minolta Holdings, Inc. | Thin-film transistor, thin-film transistor sheet and their manufacturing method |
US8177072B2 (en) * | 2008-12-04 | 2012-05-15 | Thermogenesis Corp. | Apparatus and method for separating and isolating components of a biological fluid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT72878B (en) | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5672598A (en) | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
DK0821671T3 (da) | 1995-04-20 | 2001-04-23 | Pfizer | Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer |
DK0861236T4 (da) | 1995-11-13 | 2006-12-18 | Sanofi Aventis Deutschland | Cykliske og heterocykliske N-substituerede alphaiminohydroxam- og carboxylsyrer |
FR2748026B1 (fr) | 1996-04-26 | 1998-06-05 | Adir | Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1998
- 1998-12-16 US US09/213,031 patent/US6335329B1/en not_active Expired - Fee Related
- 1998-12-18 KR KR10-2000-7006449A patent/KR100446706B1/ko not_active IP Right Cessation
- 1998-12-18 CN CN98813681A patent/CN1110482C/zh not_active Expired - Fee Related
- 1998-12-18 DK DK98964135T patent/DK1042297T3/da active
- 1998-12-18 AU AU19325/99A patent/AU746957B2/en not_active Ceased
- 1998-12-18 EP EP98964135A patent/EP1042297B1/de not_active Expired - Lifetime
- 1998-12-18 CA CA002315826A patent/CA2315826C/en not_active Expired - Fee Related
- 1998-12-18 DE DE69811734T patent/DE69811734T2/de not_active Expired - Fee Related
- 1998-12-18 AT AT98964135T patent/ATE233244T1/de not_active IP Right Cessation
- 1998-12-18 JP JP2000525389A patent/JP2001526267A/ja not_active Withdrawn
- 1998-12-18 IL IL13671798A patent/IL136717A0/xx not_active IP Right Cessation
- 1998-12-18 WO PCT/US1998/027082 patent/WO1999032452A1/en active IP Right Grant
- 1998-12-18 HU HU0100056A patent/HUP0100056A3/hu unknown
- 1998-12-18 ES ES98964135T patent/ES2191986T3/es not_active Expired - Lifetime
-
2000
- 2000-06-07 US US09/588,978 patent/US6291450B1/en not_active Expired - Fee Related
- 2000-06-12 IL IL136717A patent/IL136717A/en unknown
-
2001
- 2001-06-22 US US09/887,479 patent/US6593351B2/en not_active Expired - Fee Related
- 2001-08-08 HK HK01105515A patent/HK1034964A1/xx not_active IP Right Cessation
-
2003
- 2003-06-23 US US10/601,975 patent/US6838454B2/en not_active Expired - Fee Related
-
2004
- 2004-12-23 US US11/020,751 patent/US7022690B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2315826A1 (en) | 1999-07-01 |
HK1034964A1 (en) | 2001-11-09 |
DE69811734D1 (de) | 2003-04-03 |
ES2191986T3 (es) | 2003-09-16 |
US20040029863A1 (en) | 2004-02-12 |
IL136717A (en) | 2007-05-15 |
HUP0100056A2 (hu) | 2001-07-30 |
US20020065269A1 (en) | 2002-05-30 |
DK1042297T3 (da) | 2003-05-26 |
US6838454B2 (en) | 2005-01-04 |
KR100446706B1 (ko) | 2004-09-01 |
EP1042297A1 (de) | 2000-10-11 |
US6291450B1 (en) | 2001-09-18 |
US7022690B2 (en) | 2006-04-04 |
EP1042297B1 (de) | 2003-02-26 |
HUP0100056A3 (en) | 2002-12-28 |
KR20010033087A (ko) | 2001-04-25 |
AU1932599A (en) | 1999-07-12 |
US20050159407A1 (en) | 2005-07-21 |
JP2001526267A (ja) | 2001-12-18 |
US6335329B1 (en) | 2002-01-01 |
AU746957B2 (en) | 2002-05-09 |
US6593351B2 (en) | 2003-07-15 |
DE69811734T2 (de) | 2004-03-18 |
CN1284947A (zh) | 2001-02-21 |
CA2315826C (en) | 2004-09-14 |
CN1110482C (zh) | 2003-06-04 |
IL136717A0 (en) | 2001-06-14 |
WO1999032452A1 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69514813T2 (de) | Bicyclische diarylheterocyclen als cyclooxygenase-2-inhibitoren | |
ES2168471T3 (es) | 2-(5h)-furanonas diaril-5-oxigenadas como inhibidores de la cox-2. | |
ES2191069T3 (es) | Diaril-2-(5h)-furanonas como inhibidores de cox-2. | |
ATE366722T1 (de) | Substituierte pyridin-derivate als entzündungshemmende mittel | |
EA199900137A1 (ru) | Замещенные пиридины в качестве избирательных ингибиторов циклооксигеназы-2 | |
LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
ATE320426T1 (de) | Harnstoffderivate und ihre verwendung | |
EA200100971A1 (ru) | Новые соединения и композиции в качестве ингибиторов протеазы | |
ES2165969T3 (es) | Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios. | |
IS8175A (is) | Píperasín afleiður og aðferðir við notkun þeirra | |
EA199900057A1 (ru) | Ингибиторы матриксных металлопротеиназ | |
PT652874E (pt) | 2-heterociclico-5-hidroxi-1,3-pirimidinas uteis como agentes anti-inflamatorios | |
ES2189165T3 (es) | Nuevos compuestos macrociclicos como inhibidores de metaloproteasa. | |
ES2182035T3 (es) | Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa. | |
DE69811734D1 (de) | Carboxylsäure substituierte heterocyclische verbindungen als metalloproteinase inhibitoren | |
DE50109320D1 (de) | Verwendung von 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz | |
DE69829861D1 (de) | 2-aminopyridine als inhibitoren von cyclooxygenase-2 | |
LV12459A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
DE60008430D1 (de) | Verbindungen mit antithrombotischer wirkung | |
EA199800372A1 (ru) | Новые макроциклические соединения-ингибиторы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1042297 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |